Tong Ren Tang Technologies Co. Ltd. (HKG:1666)

Market Cap	6.10B
Revenue (ttm)	7.73B
Net Income (ttm)	555.28M
Shares Out	1.28B
EPS (ttm)	0.43
PE Ratio	10.98
Forward PE	7.94
Dividend	0.19 (3.86%)
Ex-Dividend Date	Jun 14, 2024

Volume	5,163,000
Average Volume	2,400,453
Open	4.850
Previous Close	4.990
Day's Range	4.710 - 4.850
52-Week Range	4.610 - 6.660
Beta	1.06
RSI	41.00
Earnings Date	Mar 18, 2025

About HKG:1666

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and internationally. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the wholesale and retail sale of Chinese medicines and healthcare products; technological development ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1669
• Employees: 4,101
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1666

Financial Performance

In 2024, HKG:1666's revenue was 7.26 billion, an increase of 7.18% compared to the previous year's 6.77 billion. Earnings were 521.80 million, a decrease of -11.59%.

Financial numbers in CNY